1,25-(OH)2D3/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27
Abstract Background Recent evidence has suggested that the 1,25(OH)2D3/Vitamin D receptor (VDR) acts to suppress the immune response associated with systemic lupus erythematosus (SLE), a serious multisystem autoimmune disease. Hence, the aim of the current study was to investigate the mechanism by w...
Main Authors: | Dan Liu, Yu-Xuan Fang, Xia Wu, Wei Tan, Wei Zhou, Yu Zhang, Yan-Qing Liu, Guo-Qing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-019-0488-2 |
Similar Items
-
Lower placental 25-hydroxyvitamin D3 (25(OH)D3) and higher placental CYP27B1 and 25(OH)D3 ratio in preterm birth
by: Rima Irwinda, et al.
Published: (2020-01-01) -
Downregulation of Skp2 Expression Inhibits Malignant Phenotype of Osteosarcoma U2OS Cells
by: DING Lu, et al.
Published: (2019-05-01) -
Emerging Roles of SKP2 in Cancer Drug Resistance
by: Ting Wu, et al.
Published: (2021-05-01) -
Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis
by: Ying Yang, et al.
Published: (2019-04-01) -
Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
by: Shi-Bing Zhang, et al.
Published: (2022-08-01)